These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29368865)

  • 1. Daylight photodynamic therapy: experience in the treatment of actinic keratosis in the San Gallicano Institute (Rome) and a review of literature.
    Carbone A; Sperduti I; De Simone P; Piemonte P; Ferrari A; Buccini P; Silipo V; Iorio A; Frascione P; Eibenschutz L
    G Ital Dermatol Venereol; 2020 Jun; 155(3):312-319. PubMed ID: 29368865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
    Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries.
    Fargnoli MC; Ibbotson SH; Hunger RE; Rostain G; Gaastra MTW; Eibenschutz L; Cantisani C; Venema AW; Medina S; Kerrouche N; Pérez-Garcia B
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):757-762. PubMed ID: 29136306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
    Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully home-based methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face or scalp: A real life open study.
    García-Gil MF; Gracia-Cazaña T; Cerro-Muñoz P; Bernal-Masferrer L; Navarro-Bielsa A; Gilaberte Y
    Dermatol Ther; 2022 Nov; 35(11):e15879. PubMed ID: 36184916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI).
    Jordan M; Ghoreschi K; Eberle FC
    Eur J Dermatol; 2019 Feb; 29(1):67-74. PubMed ID: 30827943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
    Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
    Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
    Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daylight Photodynamic Therapy for Actinic Keratoses.
    Morton CA; Braathen LR
    Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcipotriol as pretreatment prior to daylight-mediated photodynamic therapy in patients with actinic keratosis: A case series.
    Galimberti GN
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():172-175. PubMed ID: 29203353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
    Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
    Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study.
    Spelman L; Rubel D; Murrell DF; See JA; Hewitt D; Foley P; Salmon R; Kerob D; Pascual T; Shumack S; Fernandez-Penas P
    Australas J Dermatol; 2016 Feb; 57(1):24-8. PubMed ID: 25827200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy.
    Fai D; Romano I; Fai C; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2016 Apr; 151(2):154-9. PubMed ID: 25279493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of different photoprotection strategies in preventing actinic keratosis new lesions after photodynamic therapy. The ATHENA study: a two-center, randomized, prospective, assessor-blinded pragmatic trial.
    Pavone PS; Lovati S; Scarcella G; Milani M
    Curr Med Res Opin; 2019 Jan; 35(1):141-145. PubMed ID: 30404544
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential treatment with calcitriol and methyl aminolevulinate-daylight photodynamic therapy for patients with multiple actinic keratoses of the upper extremities.
    Piaserico S; Piccioni A; Gutiérrez Garcìa-Rodrigo C; Sacco G; Pellegrini C; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102325. PubMed ID: 33965603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of a short illumination duration (1 hour) when performing photodynamic therapy of actinic keratosis using the Dermaris light source.
    Creusot M; Mordon S
    Photodiagnosis Photodyn Ther; 2021 Dec; 36():102618. PubMed ID: 34743007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAL Daylight Photodynamic Therapy for Actinic Keratosis: Clinical and Imaging Evaluation by 3D Camera.
    Cantisani C; Paolino G; Pellacani G; Didona D; Scarno M; Faina V; Gobello T; Calvieri S
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.